diabetes glp 1 agonist Glucagon-like peptide-1 glp-1_analogs [TUSOM | Pharmwiki]

Comparison of clinical outcomes and adverse events associated with glucose-lowering drugs in patients with type 2 diabetes a meta-analysis

Novel GLP-1/GIP receptor dual agonists have also been shown to affect microglia activation and levels of pro-inflammatory cytokines [66,67]

Post-prandial levels of portal blood glucose are elevated and insulin levels decreased in rats with knockdown of GLP-1R in vagal afferent neurons, suggesting that GLP-1 also regulates blood glucose via activation of vagal afferent GLP-1 receptors [518]

Glutamate and GABA in lateral hypothalamic mechanisms controlling food intake

But the latest GLP-1 medications could offer a solution